Our specialty labs

The Quest^® Cardiometabolic Center of Excellence™ at Cleveland HeartLab^®  provides specialized laboratory testing to identify clinically silent risk factors for cardiometabolic diseases, including cardiovascular disease, type 2 diabetes, chronic kidney disease, and metabolic dysfunction-associated steatotic liver disease. Our team of experts brings you a comprehensive test menu, novel technology, innovation in chemistry, and clinical education spanning the continuum of care from risk identification to disease management.

AmeriPath^® is one of the nation’s leading providers of anatomic pathology, dermatopathology, and molecular diagnostic services to physicians, hospitals, clinical laboratories, and ambulatory surgery centers across the US. Through our nationally based, board-certified pathology teams and integrated state-of-the-art laboratories, AmeriPath is dedicated to providing comprehensive diagnostic solutions, advanced technology and testing, and superior pathology services to regional and local medical communities. With locations that provide professional component (PC) and technical component (TC) pathology services and a comprehensive test menu at all AmeriPath locations, our team of over 450 highly trained, subspecialized pathologists and PhD-level scientists deliver a clearer path to meet your pathology needs through greater diagnostic insights.

Dermpath Diagnostics^® is dedicated to providing exceptional, personalized dermatopathology services through our accessible network of over 75 board-certified dermatopathologists. Through our consistent turnaround time, detailed report results, robust 1-on-1 consultative relationships with our referring clinicians, and quality, timely insights, we light the way to the optimal treatment path and the best possible care for every patient.

Founded in 1998, PhenoPath provides a network of board-certified, subspecialty-trained pathologists who work collaboratively with referring clinicians to provide new insights for the most complex cancer cases and a clearer path forward for diagnosis, monitoring, treatment, and prognosis. Supported by Quest’s full test menu, our pathologists provide extensive experience with IHC, immunofluorescence, FISH, FLOW, PCR, cytogenetics, next-generation sequencing, and flow cytometry (10-color). They’re also dedicated to advancing critical innovations in cancer diagnostics, providing optimization and validation services for use in biomarker discovery, drug development, diagnosis, and clinical trial applications on human, animal, and xenograph samples.

Blueprint Genetics is a genetic testing company focused on inherited and sporadic diseases, syndromes, and conditions caused by genetic variants. With a patient-first mindset, Blueprint Genetics delivers high-quality genetic testing to the global clinical community supporting customers in over 70 countries and across multiple medical specialties. Based in Helsinki, Blueprint Genetics is dedicated to bringing genetic knowledge to mainstream healthcare through combining state-of-the-art laboratory processes, the latest sequencing technology, artificial intelligence (AI)-empowered data-crunching tools and techniques, world-class professionals, and a holistic customer experience approach. Blueprint Genetics aims to provide clinicians and their patients with comprehensive and high-quality tools and resources for diagnosis of genetic conditions, thereby providing possibilities for targeted treatment and individualized care for patients.

Athena Diagnostics is a specialized division of Quest Diagnostics, focused on neurogenetic and neurological disorder testing. It offers innovative tests for Alzheimer's disease, muscular dystrophy, and other neuromuscular and developmental disorders. Athena Diagnostics offers the most comprehensive test menu and intellectual property portfolio for neurological, endocrine, and renal conditions through more than 400 diagnostic tests, providing neurologists and other physicians and specialists with insights that can improve patient health.